Reneo Pharmaceuticals, Inc. (RPHM) financial statements (2022 and earlier)

Company profile

Business Address 18575 JAMBOREE ROAD
IRVINE, CA 92612
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

Current Assets
Cash, cash equivalents, and short-term investments147,670
Cash and cash equivalents124,660
Short-term investments23,010
Other undisclosed current assets6,064
Total current assets:153,734
Noncurrent Assets
Property, plant and equipment212
Other noncurrent assets78
Total noncurrent assets:290
Current Liabilities
Accounts payable and accrued liabilities6,202
Accounts payable2,022
Accrued liabilities4,180
Total current liabilities:6,202
Noncurrent Liabilities
Liabilities, other than long-term debt611
Deferred compensation liability, classified444
Deferred rent credit167
Total noncurrent liabilities:611
Total liabilities:6,813
Stockholders' equity
Stockholders' equity attributable to parent147,211
Common stock3
Additional paid in capital231,902
Accumulated other comprehensive income34
Accumulated deficit(84,728)
Total stockholders' equity:147,211

Income statement (P&L) ($ in thousands)

Operating expenses(39,818)
Operating loss:(39,818)
Nonoperating expense(252)
Foreign currency transaction loss, before tax(300)
Other nonoperating income48
Loss from continuing operations before equity method investments, income taxes:(40,070)
Other undisclosed income from continuing operations before income taxes300
Net loss available to common stockholders, diluted:(39,770)

Comprehensive Income ($ in thousands)

Net loss:(39,770)
Other comprehensive income34
Comprehensive loss, net of tax, attributable to parent:(39,736)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: